Discounted Cash Flow

Moderna, Inc.

MRNA · Based on 10 years of SEC filings

DCF estimate unavailable — only_2_profitable_out_of_10

Average annual growth rates

Metric 10-Year 5-Year 3-Year
Sales
Free Cash Flow
Average (FCF & NI)
Net Income
Dividends

Average annual growth is the mean year-over-year change across each period.

Endpoint CAGR (better for long term trend)

Metric 10-Year 5-Year 3-Year
Sales
Free Cash Flow
Average (FCF & NI)
Net Income

Endpoint CAGR is the compound annual rate from the first to last year in each period.

Projections use average year-over-year growth. Change this in Settings.

Projected growth rate

Free cash flow growth
10-year: — 5-year: — 3-year: —
Averaged growth (FCF & NI)
10-year: — 5-year: — 3-year: —
Net income growth
10-year: — 5-year: — 3-year: —
Sales growth (not added to calculations)
10-year: — 5-year: — 3-year: —

Click a greyed-out slider to switch metrics. Slide between the 10-year, 5-year, and 3-year historic growth rates for FCF, net income, or their average.

%
%

Historical inputs (10 fiscal years)

YEAR Sales Net Income Free Cash Flow Net Margin EPS (diluted)
2016 $108.4m $-216.2m $56.7m -199.5%
2017 $205.8m (89.9%) $-255.9m (-18.4%) $-351.4m (-719.6%) -124.3% (37.7%)
2018 $135.1m (-34.4%) $-384.7m (-50.3%) $-343.8m (2.2%) -284.8% (-129.1%)
2019 $60.2m (-55.4%) $-514.0m (-33.6%) $-463.6m (-34.9%) -853.7% (-199.7%)
2020 $803.4m (1234.3%) $-747.1m (-45.3%) $2.0b (533.4%) -93.0% (89.1%) $-1.96
2021 $18.5b (2199.1%) $12.2b (1733.3%) $13.5b (572.3%) 66.1% (171.0%) $30.31 (1646.4%)
2022 $19.3b (4.3%) $8.4b (-31.5%) $4.9b (-63.7%) 43.4% (-34.3%) $21.26 (-29.9%)
2023 $6.8b (-64.4%) $-4.7b (-156.4%) $-3.2b (-166.2%) -68.8% (-258.6%) $-12.33 (-158.0%)
2024 $3.2b (-52.7%) $-3.6b (24.5%) $-3.1b (4.5%) -110.0% (-59.9%) $-9.28 (24.7%)
2025 $1.9b (-39.9%) $-2.8b (20.8%) $-2.0b (36.9%) -145.2% (-31.9%) $-7.26 (21.8%)

Base FCF: (latest fiscal year)

Discount rate: %

Terminal growth:

Projection period: years

Alt A decline yrs:

Alt B total yrs:

Values abbreviated: b = billions, m = millions, k = thousands.

Projected cash flows

Year Projected cash flow Discount Factor Present Value

PV of projected FCF:

Terminal FCF:

Terminal value:

PV of terminal value:

Enterprise value (DCF):

DCF price per share:

Current price:

Alternative DCF Models

Model Fair Value Upside PV(FCFs) PV(Terminal) Total Years
Standard (10yr→TV) 10 + TV
Alt A (Gradual Decline)
Alt B (30yr Hard Stop) N/A

This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.

+ 10YR Financials Balance Sheet (10YR) Cash Flow (10YR) DCF Model

only_2_profitable_out_of_10

Once the company meets all DCF eligibility criteria (sufficient history, profitability, growth trends), an estimate will become available automatically. No action is needed.